(STKL) SunOpta - Overview
Sector: Consumer Defensive | Industry: Beverages - Non-Alcoholic | Exchange: NASDAQ (USA) | Market Cap: 771m USD | Total Return: 12.9% in 12m
Avg Turnover: 2.44M
Qual. Beats: -2
Rev. Trend: 68.3%
Qual. Beats: 0
Warnings
High Debt/EBITDA (5.9) with thin interest coverage (1.8)
Altman Z'' -0.56 < 1.0 - financial distress zone
Tailwinds
Supp Ema20, Confidence
SunOpta Inc. (STKL) specializes in the manufacturing and distribution of plant-based and fruit-based food and beverage products. Its portfolio includes plant-based milks, creamers, protein shakes, fruit snacks, and organic broths sold under proprietary brands like SOWN, Dream, and West Life. The company operates as both a consumer-facing brand owner and a business-to-business supplier, providing liquid ingredients and private-label manufacturing for global food retailers and foodservice operators.
The company operates within the packaged foods sector, where growth is increasingly driven by the shift toward alternative proteins and dairy-free substitutes. This business model relies on a diversified distribution network spanning e-commerce, club stores, and industrial food manufacturers to mitigate channel-specific volatility. For a deeper look at the fundamental metrics driving this sector, ValueRay offers additional data points. SunOptas strategic pivot toward high-growth plant-based categories follows its corporate evolution from Stake Technology Ltd. to its current structure headquartered in Minnesota.
- Expansion of high-margin plant-based milk capacity drives top-line revenue growth
- Private label beverage demand increases as consumers trade down from national brands
- Raw material price volatility for oats and almonds impacts gross margins
- Operational efficiency gains from plant consolidations improve adjusted EBITDA performance
- Growth in ready-to-drink protein shakes expands presence in high-growth beverage categories
| Net Income: 15.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.06 > 1.0 |
| NWC/Revenue: 4.10% < 20% (prev -1.38%; Δ 5.48% < -1%) |
| CFO/TA 0.07 > 3% & CFO 49.8m > Net Income 15.8m |
| Net Debt (493.4m) to EBITDA (83.5m): 5.91 < 3 |
| Current Ratio: 1.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (118.3m) vs 12m ago 1.11% < -2% |
| Gross Margin: 13.29% > 18% (prev 0.13%; Δ 1.32k% > 0.5%) |
| Asset Turnover: 120.0% > 50% (prev 108.3%; Δ 11.70% > 0%) |
| Interest Coverage Ratio: 1.82 > 6 (EBITDA TTM 83.5m / Interest Expense TTM 24.2m) |
| A: 0.05 (Total Current Assets 219.8m - Total Current Liabilities 186.2m) / Total Assets 694.7m |
| B: -0.49 (Retained Earnings -340.7m / Total Assets 694.7m) |
| C: 0.06 (EBIT TTM 44.0m / Avg Total Assets 681.6m) |
| D: 0.28 (Book Value of Equity 140.2m / Total Liabilities 508.6m) |
| Altman-Z'' = -0.56 = B |
| DSRI: 1.78 (Receivables 101.6m/50.4m, Revenue 817.7m/723.8m) |
| GMI: 0.99 (GM 13.29% / 13.12%) |
| AQI: 0.48 (AQ_t 0.04 / AQ_t-1 0.09) |
| SGI: 1.13 (Revenue 817.7m / 723.8m) |
| TATA: -0.05 (NI 15.8m - CFO 49.8m) / TA 694.7m) |
| Beneish M = -2.66 (Cap -4..+1) = A |
As of May 24, 2026, the stock is trading at USD 6.50 with a total of 2,917,348 shares traded.
Over the past week, the price has changed by +0.00%,
over one month by +0.31%,
over three months by +1.56% and
over the past year by +12.85%.
SunOpta has received a consensus analysts rating of 4.83. Therefore, it is recommended to buy STKL.
- StrongBuy: 5
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 7.5 | 15.4% |
P/E Forward = 82.6446
P/S = 0.9428
P/B = 4.5049
P/EG = 0.4812
Revenue TTM = 817.7m USD
EBIT TTM = 44.0m USD
EBITDA TTM = 83.5m USD
Long Term Debt = 217.5m USD (from longTermDebt, last quarter)
Short Term Debt = 51.5m USD (from shortTermDebt, last quarter)
Debt = 493.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 121.4m
Net Debt = 493.4m USD (calculated: Debt 493.6m - CCE 169k)
Enterprise Value = 1.26b USD (771.0m + Debt 493.6m - CCE 169k)
Interest Coverage Ratio = 1.82 (Ebit TTM 44.0m / Interest Expense TTM 24.2m)
EV/FCF = 67.03x (Enterprise Value 1.26b / FCF TTM 18.9m)
FCF Yield = 1.49% (FCF TTM 18.9m / Enterprise Value 1.26b)
FCF Margin = 2.31% (FCF TTM 18.9m / Revenue TTM 817.7m)
Net Margin = 1.93% (Net Income TTM 15.8m / Revenue TTM 817.7m)
Gross Margin = 13.29% ((Revenue TTM 817.7m - Cost of Revenue TTM 709.1m) / Revenue TTM)
Gross Margin QoQ = 13.61% (prev 11.48%)
Tobins Q-Ratio = 1.82 (Enterprise Value 1.26b / Total Assets 694.7m)
Interest Expense / Debt = 4.90% (Interest Expense 24.2m / Debt 493.6m)
Taxrate = 2.97% (177k / 5.97m)
NOPAT = 42.7m (EBIT 44.0m * (1 - 2.97%))
Current Ratio = 1.18 (Total Current Assets 219.8m / Total Current Liabilities 186.2m)
Debt / Equity = 2.65 (Debt 493.6m / totalStockholderEquity, last quarter 186.0m)
Debt / EBITDA = 5.91 (Net Debt 493.4m / EBITDA 83.5m)
Debt / FCF = 26.16 (Net Debt 493.4m / FCF TTM 18.9m)
Total Stockholder Equity = 169.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.31% (Net Income 15.8m / Total Assets 694.7m)
RoE = 3.09% (Net Income TTM 15.8m / Total Stockholder Equity 510.4m)
RoCE = 6.04% (EBIT 44.0m / Capital Employed (Equity 510.4m + L.T.Debt 217.5m))
RoIC = 7.62% (NOPAT 42.7m / Invested Capital 559.9m)
WACC = 8.97% (E(771.0m)/V(1.26b) * Re(11.67%) + D(493.6m)/V(1.26b) * Rd(4.90%) * (1-Tc(0.03)))
Discount Rate = 11.67% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 64.44 | Cagr: 1.01%
[DCF] Terminal Value 74.13% ; FCFF base≈18.4m ; Y1≈19.5m ; Y5≈22.8m
[DCF] Fair Price = N/A (negative equity: EV 317.6m - Net Debt 493.4m = -175.8m; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -2.97 | # QB: -2
Revenue Correlation: 68.34 | Revenue CAGR: 6.35% | SUE: 0.22 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.05 | Chg30d=+7.07% | Revisions=+20% | Analysts=2
EPS current Year (2026-12-31): EPS=0.23 | Chg30d=+8.49% | Revisions=N/A | GrowthEPS=+21.1% | GrowthRev=+7.5%
EPS next Year (2027-12-31): EPS=0.33 | Chg30d=N/A | Revisions=N/A | GrowthEPS=+45.6% | GrowthRev=+14.3%
[Analyst] Revisions Ratio: +20%